5861 studies found for:    vaccination
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine
Condition: Influenza
Interventions: Biological: Vaccination with Fluval P and Fluval AB influenza vaccines;   Biological: Vaccination with Fluval P monovalent influenza vaccine
2 Recruiting Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study
Conditions: Malignant Melanoma of Skin Stage III;   Malignant Melanoma of Skin Stage IV
Interventions: Other: arm 1: DC Vaccine + RT;   Other: arm 2: DC Vaccine + IFN-alfa;   Other: arm 3: both arm 1 and 2 + RT;   Biological: arm 4: DC Vaccine
3 Completed Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children
Condition: Influenza
Intervention: Biological: Vaccination with FLUVAL P
4 Completed Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents
Conditions: Novel 2009 Influenza H1N1;   Influenza, Human
Interventions: Biological: Vaccination with Fluval P monovalent influenza vaccine;   Biological: Vaccination with Fluval AB;   Biological: Vaccination with Fluval AB Novo
5 Completed Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons
Condition: Influenza
Intervention: Biological: Vaccination with Fluval AB influenza vaccine
6 Recruiting A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity Study
Condition: Innate Immune Response
Interventions: Drug: BCG Vaccine;   Drug: Hepatitis B Vaccine
7 Recruiting Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer
Condition: Breast Cancer
Interventions: Biological: LA TNBC: DC vaccine+Preop chemo;   Biological: ER+/HER2-BC:DC vaccine+Preop chemo
8 Terminated Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients
Condition: Malignant Melanoma Stage IV
Interventions: Biological: DC Vaccine & Cyclophosphamide;   Biological: DC Vaccine & Placebo
9 Completed Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant
Condition: Influenza
Interventions: Biological: Fluzone vaccine with JVRS-100 adjuvant;   Biological: Fluzone vaccine
10 Withdrawn Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1
Condition: Influenza
Interventions: Biological: Vaccine Sanofi A(H1N1) 15 ug & trivalent;   Biological: Vaccine Sanofi (H1N1) 15 ug.nonadyuvante;   Biological: Vaccine Sanofi A(H1N1) 7.5 ug
11 Active, not recruiting Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults
Condition: HIV Infection
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: Placebo for ALVAC-HIV;   Biological: Placebo for AIDSVAX B/E;   Biological: Hepatitis B vaccine;   Biological: Tetanus toxoid vaccine;   Biological: Placebo for hepatitis B vaccine;   Biological: Placebo for tetanus vaccine
12 Active, not recruiting Prospective Trial of Vaccine Responses in Childhood Cancer Survivors
Conditions: Childhood Cancer;   Multiple Diseases
Interventions: Biological: Immunization Schedule patients <7 years.;   Biological: Immunization Schedule patients > or = to 7 years and <11 years of age;   Biological: Immunization Schedule patients > or = to 11 years of age
13 Completed School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities
Conditions: Immunizations;   Vaccination;   Influenza;   School Health
Interventions: Behavioral: School based flu vaccine: Low intensity;   Behavioral: School based flu vaccine: High intensity
14 Completed Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines
Condition: Influenza
Interventions: Biological: pandemic vaccine 1;   Biological: pandemic vaccine 2;   Biological: pandemic vaccine 5;   Biological: pandemic vaccine 6;   Biological: pandemic vaccine 9;   Biological: pandemic vaccine 10;   Biological: pandmeic vaccine 11;   Biological: pandmeic vaccine 12;   Biological: pandmic vaccine 13;   Biological: placebo group 14
15 Completed
Has Results
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Condition: Influenza
Interventions: Biological: Fluzone® Quadrivalent vaccine, 2014-2015 formulation;   Biological: Fluzone I®ntradermal vaccine, 2014-2015 formulation;   Biological: Fluzone High Dose vaccine, 2014-2015 formulation
16 Completed Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine
Condition: Meningitis
Interventions: Biological: MCV-ACYW135 Vaccine Group;   Biological: MPV-ACYW135 Vaccine Group;   Biological: MPV-A Vaccine Group;   Biological: MCV-AC Vaccine Group;   Biological: Hib Vaccine Group
17 Recruiting Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study
Conditions: Intussusception;   Rotavirus Infections
Interventions: Drug: Rotarix®,;   Drug: Rotarix®, with other routine vaccines;   Drug: RotaTeq®,;   Drug: RotaTeq®, with other routine vaccines
18 Recruiting Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
Conditions: Hepatitis B;   Cirrhosis;   Awaiting Organ Transplant
Intervention: Biological: HBV vaccine
19 Completed
Has Results
Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Conditions: Meningitis;   Meningococcal Infection
Interventions: Biological: MenACWY-CRM197;   Biological: DTaP (Diptheria, Tetanus, Pertussis) Vaccine;   Biological: Hib (Haemophilus influenza b) Vaccine;   Biological: IPV (Inactivated Polio Vaccine) Vaccine;   Biological: Pneumococcal conjugate Vaccine;   Biological: MMR (Measles, Mumps, and Rubella) Vaccine;   Biological: Varicella Vaccine;   Biological: Hepatitis A Virus
20 Active, not recruiting A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Belimumab plus Early Vaccination;   Biological: Belimumab plus Late Vaccination

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years